Safety of azathioprine in pregnancy in inflammatory bowel disease
- 1 August 1990
- journal article
- research article
- Published by Elsevier in Gastroenterology
- Vol. 99 (2) , 443-446
- https://doi.org/10.1016/0016-5085(90)91027-4
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- An Immunodeficiency Characterized by Defective Signal Transduction in T LymphocytesNew England Journal of Medicine, 1989
- Neonatal pancytopenia and severe combined immunodeficiency associated with antenatal administration of azathioprine and prednisoneThe Journal of Pediatrics, 1984
- Inflammatory Bowel Disease and PregnancyJournal of Clinical Gastroenterology, 1982
- Chromosomal abberations and sister-chromatid exhanges (SCEs) in patients undergoing long-term Imuran therapyMutation Research - Fundamental and Molecular Mechanisms of Mutagenesis, 1982
- SUCCESSFUL PREGNANCIES IN WOMEN TREATED BY DIALYSIS AND KIDNEY TRANSPLANTATIONBJOG: An International Journal of Obstetrics and Gynaecology, 1980
- Effects on the neonate of prednisone and azathioprine administered to the mother during pregnancyThe Journal of Pediatrics, 1974
- Immunosuppression during pregnancy: Transmission of azathioprine and its metabolites from the mother to the fetusAmerican Journal of Obstetrics and Gynecology, 1973
- FERTILITY AFTER RENAL TRANSPLANTATIONTransplantation, 1970
- Azathioprine (Imuran) and pregnancyAmerican Journal of Obstetrics and Gynecology, 1967
- EFFECT OF 6-(1'-METHYL-4'-NITRO-5'-IMIDAZOLYL)-MERCAPTOPURINE AND 2-AMINO-6-(1'-METHYL-4'-NITRO-5'-IMIDAZOLYL)-MERCAPTOPURINE ON THE RAT LITTER IN UTEROReproduction, 1962